FREDERICK, Md. (PRWEB) October 06, 2020
Transdermal Specialties Global (TSG) a pioneer in Ultrasonic active patch delivery systems has developed a painless patented transdermal insulin delivery patch system. The U-STRIPTM uses special ultrasound frequencies to expand the pores of the skin and deliver insulin into the bloodstream for Type-1 and 2 Diabetics. No More Needles!
This patent, developed by Bruce K. Redding, Jr., CEO of Transdermal Specialties Global, uses a special Ultrasound signal to the skin, to enable large molecule drugs to be delivered using a Patch. There are only about 20 patch products on the market today, such as the motion sickness patch or birth control patch. This patented work, increases the number of Patch-Drug combinations to over 175 new products. Currently TSG is working upon an Insulin Patch as the lead product, to be followed by a Parkinson’s Patch, one for Multiple Sclerosis and a Migraine Patch.
Transdermal Specialties Global located in Frederick, MD is committed to developing innovative drug delivery systems that enhance health and improve the quality of life. The company has developed an Ultrasonic active patch delivery system U-STRIPTM that uses special ultrasound frequencies to expand the pores of the skin and deliver drugs into the bloodstream...TSG’s first product is a painless Needle-Free transdermal insulin delivery patch system. Since 2016, TSG has been a pioneer in the development of ultrasonic technologies for the pharmaceutical and cosmetic industry.
For more information on Transdermal Specialties Global, please call 484.716.2165 or visit:
Check out our Youtube channel: https://www.youtube.com/channel/UCBuYZZPj50UK1NwHm8x8BuA?